Twins Manufacturing Chemists
⚠️ High Risk
FEI: 3013086620 • Ruimveldt, GY-NOTA • GUYANA
FEI Number
3013086620
Location
Ruimveldt, GY-NOTA
Country
GUYANAAddress
31 Industrial Estate, , Ruimveldt, GY-NOTA, Guyana
High Risk
FDA Import Risk Assessment
This firm has a significant history of FDA import refusals with notable violations.
Statistics
Score Breakdown
How is this score calculated?
Proprietary Algorithm
- 40% Violation Severity — AI-assessed (1-10)
- 30% Refusal Volume — Logarithmic scale
- 20% Recency — Decays over 5 years
- 10% Frequency — Refusals per year
© ImportRefusal.com Original Analysis
Violation Summary
NUTRIT LBL
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.
UNAPPROVED
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
NOT LISTED
It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).
FRNMFGREG
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.
LACKS N/C
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(2) of the FD&C Act in that the food is in package form and the label fails to bear an accurate statement of the quantity of the contents in terms of weight, measure, or numerical count in accordance with Section 403(e)(2) of the FD&C Act.
NO ENGLISH
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(f) of the FD&C Act in that any word, statement, or other information required by or under the authority of the FD&C Act to appear on the label or labeling is not prominently placed thereon with such conspicuousness (as compared with other words, statements, designs, or devices, in the labeling) and in such terms as to render it likely to be read and understood by the ordinary individual under customary terms of purchase and use (for example, label contains information in two or more languages but fails to repeat all required information in both languages in accordance with 21 CFR 101.15(c)(2), or label fails to include all required information in English in accordance with 21 CFR 101.15(c)(1), except in the case of articles distributed solely in the Commonwealth of Puerto Rico or in a Territory where the predominant language is one other than English)).
USUAL NAME
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(1) of the FD&C Act in that the label fails to bear the common or usual name of the food, if any there be.
LIST INGRE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.
DIRSEXMPT
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.
FALSE
The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(a)(1 ) of the FD&C Act in that the labeling is false or misleading in any particular.
LABELING
The article appears in violation of FPLA because of its placement, form and/or contents statement.
COUMARIN
The article appears to bear or contain Coumarin, a poisonous or deleterious substance, which may render it injurious to health.
DRUG NAME
The article appears to be a drug and fails to bear the proprietary or established name and/or name and quantity of each active ingredient.
DIRECTIONS
The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.
Refusal History
| Date | Product | Violations | Division |
|---|---|---|---|
| 9/26/2025 | 55QY34LAVENDER OIL (PHARMACEUTIC NECESSITY - PERFUME) | Division of Northeast Imports (DNEI) | |
| 5/14/2024 | 62UBS99ANTI-TUSSIVE/COLD N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 3/26/2024 | 62UDL11DEXTROMETHORPHAN HYDROBROMIDE (ANTI-TUSSIVE/COLD) | 75UNAPPROVED | Division of Southeast Imports (DSEI) |
| 6/1/2021 | 62UBK99ANTI-TUSSIVE/COLD N.E.C. | Division of Northeast Imports (DNEI) | |
| 8/11/2020 | 60LBL01ACETAMINOPHEN (ANALGESIC) | Division of Northeast Imports (DNEI) | |
| 8/8/2019 | 62UDL99ANTI-TUSSIVE/COLD N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 11/19/2018 | 28CCT51VANILLA, NATURAL EXTRACT OR FLAVOR (SPICE) | 2080COUMARIN | Division of Northeast Imports (DNEI) |
| 3/13/2017 | 28MCT99IMITATION FLAVOR, N.E.C. | 482NUTRIT LBL | Division of Northeast Imports (DNEI) |
| 3/13/2017 | 28MCT99IMITATION FLAVOR, N.E.C. | 482NUTRIT LBL | Division of Northeast Imports (DNEI) |
| 3/13/2017 | 28MCT99IMITATION FLAVOR, N.E.C. | 482NUTRIT LBL | Division of Northeast Imports (DNEI) |
| 3/13/2017 | 28MCT99IMITATION FLAVOR, N.E.C. | 482NUTRIT LBL | Division of Northeast Imports (DNEI) |
| 3/13/2017 | 28MCT99IMITATION FLAVOR, N.E.C. | 482NUTRIT LBL | Division of Northeast Imports (DNEI) |
| 3/13/2017 | 62MBJ08MENTHOL (ANTI-PRURITIC) | Division of Northeast Imports (DNEI) | |
| 9/8/2016 | 45LC99FLAVORING AGENTS AND ADJUVANTS (FOOD ADDITIVES FOR HUMAN USE) | Division of Northeast Imports (DNEI) | |
| 9/8/2016 | 45LC99FLAVORING AGENTS AND ADJUVANTS (FOOD ADDITIVES FOR HUMAN USE) | 321LACKS N/C | Division of Northeast Imports (DNEI) |
| 9/8/2016 | 28CCT02ALMOND, NATURAL EXTRACT OR FLAVOR (SPICE) | Division of Northeast Imports (DNEI) | |
| 9/8/2016 | 45LC99FLAVORING AGENTS AND ADJUVANTS (FOOD ADDITIVES FOR HUMAN USE) | Division of Northeast Imports (DNEI) | |
| 1/22/2016 | 54AYL99VITAMIN, N.E.C. | 75UNAPPROVED | Division of Northeast Imports (DNEI) |
| 11/19/2014 | 62UBY07CODEINE (ANTI-TUSSIVE/COLD) | 118NOT LISTED | Division of Northeast Imports (DNEI) |
| 8/11/2010 | 64NDK08IRON SORBITEX (HEMATINIC) | 473LABELING | New York District Office (NYK-DO) |
Frequently Asked Questions
What is Twins Manufacturing Chemists's FDA import refusal history?
Twins Manufacturing Chemists (FEI: 3013086620) has 20 FDA import refusal record(s) in our database, spanning from 8/11/2010 to 9/26/2025.
What is an FEI number?
FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Twins Manufacturing Chemists's FEI number is 3013086620.
What types of violations has Twins Manufacturing Chemists received?
Twins Manufacturing Chemists has been cited for 14 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.
Where does this information about Twins Manufacturing Chemists come from?
All FDA import refusal data for Twins Manufacturing Chemists is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.